{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:58:21Z","timestamp":1794362301439,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41593-019-0370-y","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T12:04:09Z","timestamp":1554725049000},"page":"729-740","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":488,"title":["Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39"],"prefix":"10.1038","volume":"22","author":[{"given":"Maisa C.","family":"Takenaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Gabriely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rothhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan D.","family":"Mascanfroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Cheih","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Guti\u00e9rrez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kenison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Tjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Vandeventer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalil Alves","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Rothweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soufiene","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zandee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-2216","authenticated-orcid":false,"given":"Luke","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio F.","family":"Farez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-0580","authenticated-orcid":false,"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8156-0736","authenticated-orcid":false,"given":"Francisco J.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20554","volume":"539","author":"O Henau De","year":"2016","unstructured":"De Henau, O. et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells. Nature 539, 443\u2013447 (2016).","journal-title":"Nature"},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature19834","volume":"539","author":"MM Kaneda","year":"2016","unstructured":"Kaneda, M. M. et al. PI3K\u03b3 is a molecular switch that controls immune suppression. Nature 539, 437\u2013442 (2016).","journal-title":"Nature"},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"aad3018","DOI":"10.1126\/science.aad3018","volume":"352","author":"DF Quail","year":"2016","unstructured":"Quail, D. F. et al. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science 352, aad3018 (2016).","journal-title":"Science"},{"key":"370_CR4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423\u20131437 (2013).","journal-title":"Nat. Med."},{"key":"370_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"370_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","volume":"124","author":"J Condeelis","year":"2006","unstructured":"Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263\u2013266 (2006).","journal-title":"Cell"},{"key":"370_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin, R. A. et al. The cellular and molecular origin of tumor-associated macrophages. Science 344, 921\u2013925 (2014).","journal-title":"Science"},{"key":"370_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila, M. R. & de Sauvage, F. J. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346\u2013354 (2013).","journal-title":"Nature"},{"key":"370_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222\u2013225 (2011).","journal-title":"Nature"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39\u201351 (2010).","journal-title":"Cell"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneurol.2015.139","volume":"11","author":"M Preusser","year":"2015","unstructured":"Preusser, M., Lim, M., Hafler, D. A., Reardon, D. A. & Sampson, J. H. Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nat. Rev. Neurol. 11, 504\u2013514 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56\u201361 (2015).","journal-title":"Science"},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrneurol.2015.242","volume":"12","author":"PY Wen","year":"2016","unstructured":"Wen, P. Y. & Reardon, D. A. Neuro-oncology in 2015: progress in glioma diagnosis, classification and treatment. Nat. Rev. Neurol. 12, 69\u201370 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan, D., Gutmann, D. H. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20\u201327 (2016).","journal-title":"Nat. Neurosci."},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/neuonc\/nou363","volume":"17","author":"AA Thomas","year":"2015","unstructured":"Thomas, A. A. et al. Regulatory T cells are not a strong predictor of survival for patients with glioblastoma. Neuro Oncol. 17, 801\u2013809 (2015).","journal-title":"Neuro Oncol"},{"key":"370_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck, S. M. et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264\u20131272 (2013).","journal-title":"Nat. Med."},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2014.11.023","volume":"159","author":"D Gosselin","year":"2014","unstructured":"Gosselin, D. et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327\u20131340 (2014).","journal-title":"Cell"},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S. & Bronte, V. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253\u2013268 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.tem.2017.02.009","volume":"28","author":"G Gabriely","year":"2017","unstructured":"Gabriely, G., Wheeler, M. A., Takenaka, M. C. & Quintana, F. J. Role of AHR and HIF-1\u03b1 in glioblastoma metabolism. Trends Endocrinol. Metab. 28, 428\u2013436 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"370_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203 (2011).","journal-title":"Nature"},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","volume":"48","author":"C Guti\u00e9rrez-V\u00e1zquez","year":"2018","unstructured":"Guti\u00e9rrez-V\u00e1zquez, C. & Quintana, F. J. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48, 19\u201333 (2018).","journal-title":"Immunity"},{"key":"370_CR23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","volume":"21","author":"ID Mascanfroni","year":"2015","unstructured":"Mascanfroni, I. D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1. Nat. Med. 21, 638\u2013646 (2015).","journal-title":"Nat. Med."},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature13323","volume":"511","author":"A Bessede","year":"2014","unstructured":"Bessede, A. et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511, 184\u2013190 (2014).","journal-title":"Nature"},{"key":"370_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41586-018-0119-x","volume":"557","author":"V Rothhammer","year":"2018","unstructured":"Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724\u2013728 (2018).","journal-title":"Nature"},{"key":"370_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0627-5","volume":"13","author":"R Mukthavaram","year":"2015","unstructured":"Mukthavaram, R. et al. Effect of the JAK2\/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres. J. Transl Med. 13, 269 (2015).","journal-title":"J. Transl Med."},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3171\/2014.4.JNS131198","volume":"121","author":"B Thota","year":"2014","unstructured":"Thota, B. et al. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma. J. Neurosurg. 121, 374\u2013383 (2014).","journal-title":"J. Neurosurg."},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.4106","volume":"22","author":"V Rothhammer","year":"2016","unstructured":"Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586\u2013597 (2016).","journal-title":"Nat. Med."},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462\u2013477 (2013).","journal-title":"Cell"},{"key":"370_CR30","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","DOI":"10.1038\/nature07385"},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.celrep.2016.10.052","volume":"17","author":"RL Bowman","year":"2016","unstructured":"Bowman, R. L. et al. Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Rep. 17, 2445\u20132459 (2016).","journal-title":"Cell Rep."},{"key":"370_CR32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.10679","volume":"54","author":"M Platten","year":"2003","unstructured":"Platten, M. et al. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol. 54, 388\u2013392 (2003).","journal-title":"Ann. Neurol."},{"key":"370_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/nm.3681","volume":"20","author":"L Mayo","year":"2014","unstructured":"Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147\u20131156 (2014).","journal-title":"Nat. Med."},{"key":"370_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1476-9255-2-14","volume":"2","author":"RJ Phillips","year":"2005","unstructured":"Phillips, R. J., Lutz, M. & Premack, B. Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J. Inflamm. (Lond.) 2, 14 (2005).","journal-title":"J. Inflamm. (Lond.)"},{"key":"370_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/jlb.62.1.30","volume":"62","author":"S Sozzani","year":"1997","unstructured":"Sozzani, S. et al. MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J. Leukoc. Biol. 62, 30\u201333 (1997).","journal-title":"J. Leukoc. Biol."},{"key":"370_CR36","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","volume":"310","author":"M Platten","year":"2005","unstructured":"Platten, M. et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310, 850\u2013855 (2005).","journal-title":"Science"},{"key":"370_CR37","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1172\/JCI45444","volume":"121","author":"X Liao","year":"2011","unstructured":"Liao, X. et al. Kr\u00fcppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121, 2736\u20132749 (2011).","journal-title":"J. Clin. Invest."},{"key":"370_CR38","doi-asserted-by":"publisher","first-page":"ra61","DOI":"10.1126\/scisignal.aad0612","volume":"9","author":"A Yeste","year":"2016","unstructured":"Yeste, A. et al. Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2. Sci. Signal. 9, ra61 (2016).","journal-title":"Sci. Signal."},{"key":"370_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","volume":"37","author":"MC Takenaka","year":"2016","unstructured":"Takenaka, M. C., Robson, S. & Quintana, F. J. Regulation of the T cell response by CD39. Trends Immunol. 37, 427\u2013439 (2016).","journal-title":"Trends Immunol."},{"key":"370_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257\u20131265 (2007).","journal-title":"J. Exp. Med."},{"key":"370_CR41","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","volume":"166","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. A distinct gene module for dysfunction uncoupled from activation in tumor-infiltrating T Cells. Cell 166, 1500\u20131511.e9 (2016).","journal-title":"Cell"},{"key":"370_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"370_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"370_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2017.06.016","volume":"170","author":"CJ Nirschl","year":"2017","unstructured":"Nirschl, C. J. et al. IFN\u03b3-dependent tissue-immune homeostasis is co-opted in the tumor microenvironment. Cell 170, 127\u2013141 (2017).","journal-title":"Cell"},{"key":"370_CR45","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32, 42\u201356.e6 (2017).","journal-title":"Cancer Cell"},{"key":"370_CR46","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"370_CR47","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1172\/JCI90644","volume":"127","author":"G Kohanbash","year":"2017","unstructured":"Kohanbash, G. et al. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J. Clin. Invest. 127, 1425\u20131437 (2017).","journal-title":"J. Clin. Invest."},{"key":"370_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature18847","volume":"535","author":"CA Thaiss","year":"2016","unstructured":"Thaiss, C. A., Zmora, N., Levy, M. & Elinav, E. The microbiome and innate immunity. Nature 535, 65\u201374 (2016).","journal-title":"Nature"},{"key":"370_CR49","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"370_CR50","first-page":"823","volume":"35","author":"AB Okey","year":"1989","unstructured":"Okey, A. B., Vella, L. M. & Harper, P. A. Detection and characterization of a low affinity form of cytosolic Ah receptor in livers of mice nonresponsive to induction of cytochrome P1-450 by 3-methylcholanthrene. Mol. Pharmacol. 35, 823\u2013830 (1989).","journal-title":"Mol. Pharmacol."},{"key":"370_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1126\/sciimmunol.aaj1738","volume":"2","author":"G Gabriely","year":"2017","unstructured":"Gabriely, G. et al. Targeting latency-associated peptide promotes antitumor immunity. Sci. Immunol. 2, 2 (2017).","journal-title":"Sci. Immunol."},{"key":"370_CR52","doi-asserted-by":"publisher","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","volume":"113","author":"ML Bennett","year":"2016","unstructured":"Bennett, M. L. et al. New tools for studying microglia in the mouse and human CNS. Proc. Natl Acad. Sci. USA 113, E1738\u2013E1746 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"370_CR53","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-62703-520-0_19","volume":"1041","author":"BA Durafourt","year":"2013","unstructured":"Durafourt, B. A., Moore, C. S., Blain, M. & Antel, J. P. Isolating, culturing, and polarizing primary human adult and fetal microglia. Methods Mol. Biol. 1041, 199\u2013211 (2013).","journal-title":"Methods Mol. Biol."},{"key":"370_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/imm.12706","volume":"151","author":"BA David","year":"2017","unstructured":"David, B. A. et al. Isolation and high-dimensional phenotyping of gastrointestinal immune cells. Immunology 151, 56\u201370 (2017).","journal-title":"Immunology"},{"key":"370_CR55","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ni.2695","volume":"14","author":"ID Mascanfroni","year":"2013","unstructured":"Mascanfroni, I. D. et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 14, 1054\u20131063 (2013).","journal-title":"Nat. Immunol."},{"key":"370_CR56","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.1128\/MCB.00915-07","volume":"27","author":"S Shin","year":"2007","unstructured":"Shin, S. et al. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol. Cell. Biol. 27, 7188\u20137197 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"370_CR57","doi-asserted-by":"publisher","first-page":"e93362","DOI":"10.1371\/journal.pone.0093362","volume":"9","author":"M Karpurapu","year":"2014","unstructured":"Karpurapu, M. et al. Kr\u00fcppel like factor 4 promoter undergoes active demethylation during monocyte\/macrophage differentiation. PLoS One 9, e93362 (2014).","journal-title":"PLoS One"}],"updated-by":[{"DOI":"10.1038\/s41593-019-0446-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000}}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41593-019-0370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41593-019-0370-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41593-019-0370-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:18:09Z","timestamp":1684606689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-019-0370-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1038\/s41593-019-0370-y","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of this article initially published, author Alexandre Prat\u2019s surname was misspelled. The error has been corrected in the HTML and PDF versions of the article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.J.Q. is a member of the Scientific Advisory Board of Kyn Therapeutics. D.S. is a co-founder of and holds equity in Hercules Pharmaceuticals. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}